精益管理在卒中中心脑梗死单病种成本控制中的应用
该回顾性研究纳入台州中心医院卒中中心接受静脉溶栓的急性脑梗死患者,对照组30例采用传统管理流程(2016年7月至2017年9月),精益组32例采用精益管理价值流优化流程(2017年10月至2018年12月),将溶栓地点从神经内科病房改为急诊神经重症监护病房(NICU)。结果显示,精益组DNT、T1、T2均显著缩短,DNT控制在40分钟内的比例显著提高(75.0% vs 16.7%),7天NIHSS评分显著降低、Barthel指数显著升高,住院日缩短、住院费用降低、患者满意度提高。结论认为精益思维可实现卒中中心流程标准化、有效利用医疗资源、提高医疗质量并降低脑梗死单病种成本。
要点
- 精益组DNT 39.56±11.12分钟 vs 对照组63.03±19.63分钟,显著缩短(P<0.01)。
- DNT控制在40分钟内的比例精益组75.0%(24/32)vs 对照组16.7%(5/30),显著提高(P<0.01)。
- 7天NIHSS评分精益组8.66±4.12 vs 对照组13.00±5.63,显著降低(P<0.01);7天Barthel指数71.6±16.7 vs 54.7±17.1,显著升高(P<0.01)。
- 住院日精益组9.69±4.06天 vs 对照组12.47±3.83天,显著缩短(P<0.01);住院费用16338±5481元 vs 19470±5495元,显著降低(P<0.05)。
- 精益管理将溶栓地点由神经内科病房改为急诊神经重症监护病房(NICU),并建立卒中救治绿色通道以尽可能消除等待时间。
适用人群与场景
- 在台州中心医院卒中中心接受静脉溶栓的急性脑梗死(ACI)患者;对照组为2016年7月至2017年9月采用传统管理流程的30例患者,精益组为2017年10月至2018年12月接受精益管理的32例患者。
处置流程与药物剂量
- 对照组采用传统静脉溶栓流程,患者被送至神经内科病房进行静脉溶栓。
- 精益组应用精益管理价值流优化流程管理,成立卒中中心精益管理团队,建立卒中救治绿色通道以尽可能消除等待时间。
- 精益组将溶栓地点从神经内科病房改为急诊神经重症监护病房(NICU)。
研究设计与关键结果
- 研究类型为回顾性研究,纳入台州中心医院卒中中心接受静脉溶栓的急性脑梗死患者,对照组30例、精益组32例。
- 与对照组相比,精益组DNT显著缩短(分钟:39.56±11.12 vs 63.03±19.63,P<0.01),T1显著缩短(分钟:16.23±6.79 vs 33.48±12.63,P<0.01),T2显著缩短(分钟:13.45±3.84 vs 17.47±5.56,P<0.01),T3略缩短(分钟:9.88±1.95 vs 10.95±2.69,P>0.05)。
- DNT控制在40分钟内的比例精益组显著高于对照组[75.0%(24/32)vs 16.7%(5/30),P<0.01]。
- 溶栓后7天NIHSS评分精益组显著低于对照组(8.66±4.12 vs 13.00±5.63,P<0.01),7天Barthel指数精益组显著高于对照组(71.6±16.7 vs 54.7±17.1,P<0.01)。
- 住院日精益组显著短于对照组(天:9.69±4.06 vs 12.47±3.83,P<0.01),住院费用精益组显著低于对照组(元:16338±5481 vs 19470±5495,P<0.05),患者满意度精益组显著高于对照组[(91.38±2.69)% vs(86.53±2.78)%,P<0.01]。
- 脑梗死单病种主要过程质量与易遗漏指标实施率方面,精益组较对照组显著提高:溶栓药物用药前评估[87.5%(28/32)vs 53.3%(16/30)]、吞咽功能评估[96.9%(31/32)vs 73.3%(22/30)]、血管功能评估[78.1%(25/32)vs 43.3%(13/30)]、急性脑梗死健康教育[100.0%(32/32)vs 76.7%(23/30)]、24小时内康复评估与实施[75.0%(24/32)vs 33.3%(10/30)],均P<0.05。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为精益思维可实现卒中中心流程标准化、有效利用医疗资源、提高医疗质量并降低脑梗死单病种成本。
- 该研究将溶栓地点由神经内科病房改为急诊神经重症监护病房(NICU)并建立卒中救治绿色通道,与DNT缩短及DNT≤40分钟比例提高相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the effect of lean management on cost control of single disease in patients with acute cerebral infarction (ACI) in stroke center.
METHODS: A retrospective study was conducted. The patients with ACI who underwent intravenous thrombolysis in the stroke center of Taizhou Central Hospital in Zhejiang Province were enrolled. Thirty patients adopted traditional management procedures from July 2016 to September 2017 were enrolled in the control group, and 32 patients received lean management from October 2017 to December 2018 were enrolled in the lean group. The patients in the control group were treated with traditional intravenous thrombolysis, and the patients were sent to the neurology ward for intravenous thrombolysis. The patients in the lean group applied lean management value stream to optimize process management, the lean management team of the stroke center was established, and the green channel for stroke treatment was established to eliminate the waiting time as far as possible. The location of thrombolysis was changed from neurology ward to the neurological intensive care unit (NICU) in emergency department. The patients in the two groups were compared in terms of intravenous thrombolytic door-to-needle time (DNT), admission time to the neurologist's visit time (T1), CT examination time to neurology ward or NICU admission time (T2), neurology ward/NICU visit time to medication time (T3), and the proportion of patients with DNT controlled within 40 minutes, recovery of neurological impairment 7 days after thrombolysis [national institutes of health stroke scale (NIHSS) score], activity of daily living assessment (Barthel index), length of hospital stay, cost of hospital stay and patient satisfaction. At the same time, the main process quality and the implementation rate of easily missed indexes of cerebral infarction single disease were recorded.
RESULTS: Compared with the control group, DNT, T1 and T2 in the lean group were significantly shortened [DNT (minutes): 39.56±11.12 vs. 63.03±19.63, T1 (minutes): 16.23±6.79 vs. 33.48±12.63, T2 (minutes): 13.45±3.84 vs. 17.47±5.56, all P < 0.01], T3 was slightly shortened (minutes: 9.88±1.95 vs. 10.95±2.69, P > 0.05), and the proportion of DNT control within 40 minutes was significantly increased [75.0% (24/32) vs. 16.7% (5/30), P < 0.01], the 7-day NIHSS score was decreased significantly (8.66±4.12 vs. 13.00±5.63, P < 0.01), 7-day Barthel index was increased significantly (71.6±16.7 vs. 54.7±17.1, P < 0.01), the length of hospital stay was significantly shortened (days: 9.69±4.06 vs. 12.47±3.83, P < 0.01), the hospital costs were significantly reduced (Yuan: 16 338±5 481 vs. 19 470±5 495, P < 0.05), the satisfaction of patients was improved significantly [(91.38±2.69)% vs. (86.53±2.78)%, P < 0.01]. In terms of the implementation rate of quality indicators such as pre-application evaluation of thrombolytic drugs, evaluation of dysphagia, and evaluation of vascular function, health education of ACI, rehabilitation evaluation and implementation within 24 hours, etc., the lean group was significantly improved as compared with the control group [(87.5% (28/32) vs. 53.3% (16/30), 96.9% (31/32) vs. 73.3% (22/30), 78.1% (25/32) vs. 43.3% (13/30), 100.0% (32/32) vs. 76.7% (23/30), 75.0% (24/32) vs. 33.3% (10/30), all P < 0.05].
CONCLUSIONS: Lean thinking can realize the standardization of stroke center process, effectively utilize medical resources, improve medical quality and reduce the cost of cerebral infarction single disease.
参考来源
- Qin C, Pan L, Chen Q, et al. [Application of lean management in cost control of cerebral infarction single disease in stroke center]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31198155. doi:10.3760/cma.j.issn.2095-4352.2019.05.023
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。